Understanding this immune link changes how researchers think about statin side effects. Instead of blaming metabolism or simple wear-and-tear, the work points to specific molecules and pathways that could be blocked or dampened. That opens a path to targeted therapies that keep the cardiovascular benefits intact while shielding muscles from injury.
For patients and clinicians, the promise lies in more choices and fewer trade-offs. If follow-up studies confirm these mechanisms, future treatments could let people stay on proven heart-protective drugs without losing strength or enjoyment of exercise. Follow the original research to see which immune players are involved and how this could reshape care for people who need statins.
Scientists have identified an immune response that may explain why statins cause muscle pain, weakness, and exercise intolerance in some people. The finding could eventually lead to treatments that protect muscles while preserving the drugs’ lifesaving cardiovascular benefits.
